Dose-Dependent Regulation of High-Density Lipoprotein Metabolism with Rosuvastatin in the Metabolic Syndrome | Zendy

Esther Ooi | Zendy; Gerald F. Watts | Zendy; Paul J. Nestel | Zendy; Dmitri Sviridov | Zendy; Anh Hoang | Zendy; P. Hugh R. Barrett | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dose-Dependent Regulation of High-Density Lipoprotein Metabolism with Rosuvastatin in the Metabolic Syndrome

Author(s) -

Esther Ooi,

Gerald F. Watts,

Paul J. Nestel,

Dmitri Sviridov,

Anh Hoang,

P. Hugh R. Barrett

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2007-0854

Subject(s) - medicine , endocrinology , rosuvastatin , apolipoprotein b , metabolic syndrome , cholesterol , catabolism , high density lipoprotein , lipoprotein , triglyceride , chemistry , metabolism , diabetes mellitus

Low plasma concentration of high-density lipoprotein (HDL) cholesterol is a risk factor for cardiovascular disease and a feature of the metabolic syndrome. Rosuvastatin has been shown to increase HDL cholesterol concentration, but the mechanisms remain unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research